References
Saban N, Bujak M (2009) Hydroxyurea and hydroxamic acid derivatives as antitumor drugs. Cancer Chemother Pharmacol 64(2):213–221
Dingli D, Tefferi A (2006) Hydroxyurea: the drug of choice for polycythemia vera and essential thrombocythemia. Curr Hematol Malig Rep 1(2):69–74
Sevastos N, Theodossiades G, Savvas SP, Tsilidis K, Efstathiou S, Archimandritis AJ (2006) Pseudohyperkalaemia in patients with increased cellular components of blood. Am J Med Sci 331(1):17–21
Hollander-Rodriguez JC, Calvert JF Jr (2006) Hyperkalaemia. Am Fam Physician 73(2):283–290
Perazella MA (2000) Drug-induced hyperkalaemia: old culprits and new offenders. Am J Med 109(4):307–314
Naranjo CA, Busto U, Seller EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marusic, S., Gojo-Tomic, N., Bacic-Vrca, V. et al. Hyperkalaemia associated with hydroxyurea in a patient with polycythaemia vera. Eur J Clin Pharmacol 67, 757–758 (2011). https://doi.org/10.1007/s00228-010-0962-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-010-0962-7